Source: BioPortfolio

OyaGen: OyaGen Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 10052018 Prices from USD $250

SummaryOyaGen Inc OyaGen is a biotechnology company which discovers develops and commercializes novel pharmaceutical therapies. It offers products that include viral infectivity factor Vif Dimerization Antagonist Vif Interaction with APOBEC3G Vif dependent...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Harold Smith's photo - President & CEO of OyaGen

President & CEO

Harold Smith

CEO Approval Rating

73/100

Read more